CLINICAL_TRIALS
research
· 2014-12-18
Clinical Trial Update: A Safety Study in Patients With Chronic Lymphocytic Leukemia [Phase 1, Phase 2]
Summary
This document notes a completed Phase 1/Phase 2 safety study in patients with chronic lymphocytic leukemia sponsored by Seagen.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seagen Inc. | Conditions: Leukemia, Lymphocytic, Chronic | Phase 1, Phase 2 | Status: COMPLETED